Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642486 · ClinicalTrials.gov registry record · NA
Portable Monitoring for Diagnosis and Management of Sleep Apnea
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 373
- Enrollment target
NCT00642486: Completed NA study, sponsored by Case Western Reserve University.
NCT00642486 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 373 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00642486, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 373 participants
- Enrollment target
Study Summary
This multi-site project compares compares the efficiency of a home-based portable monitoring strategy to a standard of care sleep laboratory-based strategy for the diagnosis and positive airway pressure treatment of obstructive sleep apnea in adults.
Interventions
- OTHER Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex)
- OTHER Standard polysomnography (PSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00642486 record still lists
NCT00642486 is an interventional study that assigns participants to a tested intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex) is the first listed.
NCT00642486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00642486 about?
NCT00642486 is a clinical study titled "Portable Monitoring for Diagnosis and Management of Sleep Apnea". This multi-site project compares compares the efficiency of a home-based portable monitoring strategy to a standard of care sleep laboratory-based strategy for the diagnosis and positive airway pressure treatment of obstructive sleep apnea in adults.
What is the current status of trial NCT00642486?
This trial is currently completed. It is a NA study. The enrollment target is 373 participants. The study started on 2008-02. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00642486?
The interventions under investigation include: Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex) (OTHER), Standard polysomnography (PSG) (OTHER).
Who is sponsoring clinical trial NCT00642486?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00642486's enrollment target sits among peer trials
373 280th of 2000 higher than 1,721 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07276750 · 373 participants · NA
Coaching and Leadership in Autism Support Settings
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia